Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

The effect of St John's Wort on the pharmacodynamic response of clopidogrel in hyporesponsive volunteers and patients: increased platelet inhibition by enhancement of CYP3A4 metabolic activity.

Lau WC, Welch TD, Shields T, Rubenfire M, Tantry US, Gurbel PA.

J Cardiovasc Pharmacol. 2011 Jan;57(1):86-93. doi: 10.1097/FJC.0b013e3181ffe8d0.

PMID:
20980920
2.

Genetic determinants of on-clopidogrel high platelet reactivity.

Campo G, Miccoli M, Tebaldi M, Marchesini J, Fileti L, Monti M, Valgimigli M, Ferrari R.

Platelets. 2011;22(6):399-407. doi: 10.3109/09537104.2011.579648. Epub 2011 May 31. Review.

PMID:
21627411
3.

[Statin and clopidogrel pharmacological interaction].

Leoncini M, Toso A, Maioli M, Bellandi F.

G Ital Cardiol (Rome). 2013 Sep;14(9):574-84. doi: 10.1714/1311.14483. Review. Italian.

PMID:
23903277
4.

Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans.

Farid NA, Kurihara A, Wrighton SA.

J Clin Pharmacol. 2010 Feb;50(2):126-42. doi: 10.1177/0091270009343005. Epub 2009 Nov 30. Review. Erratum in: J Clin Pharmacol. 2010 Apr;50(4):483.

PMID:
19948947
5.

Clopidogrel resistance: pharmacokinetic or pharmacogenetic?

Ford NF.

J Clin Pharmacol. 2009 May;49(5):506-12. doi: 10.1177/0091270009332433. Epub 2009 Feb 26. Review.

PMID:
19246723

Supplemental Content

Support Center